Cullinan Therapeutics, Inc. · Brief

Next report

4 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 8≥ implied

Feb 27 '25±11.2%▲+1.89%×0.17

May 8 '25±6.7%▲+0.91%×0.14

Aug 7 '25±56.2%▼−10.79%×0.19

Q3 FY25±13.0%▲+0.55%×0.04

Jan 8 '26±15.3%▲+1.83%×0.12

Q1 FY26±25.3%▼−2.61%×0.10

May 7 '26±28.5%▼−1.80%×0.06

Q2 FY26±23.3%▲+1.93%×0.08

quarterimplied−60%0+60%realized×

Q2 FY26±23.3%▲+1.93%×0.08

May '26±28.5%▼−1.80%×0.06

Q1 FY26±25.3%▼−2.61%×0.10

Jan '26±15.3%▲+1.83%×0.12

Q3 FY25±13.0%▲+0.55%×0.04

Aug '25±56.2%▼−10.79%×0.19

2 older reports

May '25±6.7%▲+0.91%×0.14

Feb '25±11.2%▲+1.89%×0.17

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2 of 3

184managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+18.24%change in shares held by the largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports where the move came in under the options implied rangeEarnings history

2 of 24largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

CGEM report session

No linked exposure.

Oct 22impliedImplied move: ±30.0% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.